| scholarly article | Q13442814 |
| P50 | author | Boris W Kramer | Q92195809 |
| Tim Wolfs | Q64658265 | ||
| P2093 | author name string | Matthias C Hütten | |
| P2860 | cites work | Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth | Q24200191 |
| Prophylactic methylxanthines for endotracheal extubation in preterm infants | Q24235753 | ||
| Observing the resuscitation of very preterm infants: are we able to follow the oxygen saturation targets? | Q86046077 | ||
| Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthweight infants | Q24235882 | ||
| Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth | Q24245169 | ||
| New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs | Q27313764 | ||
| Caffeine Therapy for Apnea of Prematurity | Q29395883 | ||
| Silent chorioamnionitis and associated pregnancy outcomes: a review of clinical data gathered over a 16-year period | Q30732876 | ||
| Antenatal and postnatal corticosteroid and resuscitation induced lung injury in preterm sheep | Q33574324 | ||
| Developmental determinants and changing patterns of respiratory outcomes after preterm birth | Q33699711 | ||
| Update on oxygen radical disease in neonatology | Q34227606 | ||
| A clinical prediction rule for histological chorioamnionitis in preterm newborns | Q34447022 | ||
| Synergistic effect of caffeine and glucocorticoids on expression of surfactant protein B (SP-B) mRNA. | Q34525344 | ||
| Retinoids, alveolus formation, and alveolar deficiency: clinical implications | Q35069037 | ||
| Chronic fetal exposure to Ureaplasma parvum suppresses innate immune responses in sheep | Q35175409 | ||
| Intra-amniotic LPS and antenatal betamethasone: inflammation and maturation in preterm lamb lungs | Q35786756 | ||
| The significance of vitamin A for the development and function of the lung | Q36087251 | ||
| The clever fetus: responding to inflammation to minimize lung injury | Q36279596 | ||
| Genetic predisposition to bronchopulmonary dysplasia | Q36279634 | ||
| Respiratory consequences of preterm birth. | Q36399886 | ||
| LPS-induced chorioamnionitis and antenatal corticosteroids modulate Shh signaling in the ovine fetal lung. | Q36454401 | ||
| Inflammation and bronchopulmonary dysplasia: a continuing story | Q36479482 | ||
| Antenatal glucocorticoids counteract LPS changes in TGF-β pathway and caveolin-1 in ovine fetal lung | Q36700004 | ||
| Progress in understanding the pathogenesis of BPD using the baboon and sheep models | Q36877324 | ||
| Prenatal inflammation and lung development | Q37121026 | ||
| Sustained inflation at birth did not protect preterm fetal sheep from lung injury | Q37147115 | ||
| Injury and inflammation from resuscitation of the preterm infant | Q37285622 | ||
| Oxygen in health and disease: regulation of oxygen homeostasis--clinical implications | Q37293099 | ||
| Resuscitation of preterm neonates with limited versus high oxygen strategy | Q37337412 | ||
| Histological chorioamnionitis and respiratory outcome in preterm infants | Q37364972 | ||
| Airway injury from initiating ventilation in preterm sheep. | Q37480469 | ||
| Accuracy of C-reactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: a systematic review | Q37612533 | ||
| Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants | Q37700718 | ||
| Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants | Q37711013 | ||
| Oxygen toxicity: chemistry and biology of reactive oxygen species | Q37759910 | ||
| Caffeine impact on neonatal morbidities | Q37793063 | ||
| Neonatal resuscitation for the preterm infant: evidence versus practice | Q37793850 | ||
| Antenatal steroids and neonatal outcome after chorioamnionitis: a meta-analysis | Q37807517 | ||
| Oxygen saturation targets for preterm infants in the delivery room. | Q37990541 | ||
| What is RDS in 2012? | Q38013417 | ||
| Thrown off balance: the effect of antenatal inflammation on the developing lung and immune system | Q38073533 | ||
| The preterm lung and airway: past, present, and future | Q38099915 | ||
| Systematic review and meta-analysis of optimal initial fraction of oxygen levels in the delivery room at ≤32 weeks | Q38203332 | ||
| Patterns and etiology of acute and chronic lung injury: insights from experimental evidence | Q38214244 | ||
| Oxygen supplementation in the neonatal period: changing the paradigm | Q38220422 | ||
| Automated adjustments of inspired fraction of oxygen to avoid hypoxemia and hyperoxemia in neonates - a systematic review on clinical studies | Q38227944 | ||
| Serum caffeine concentrations and short-term outcomes in premature infants of ⩽29 weeks of gestation. | Q38292969 | ||
| Closed-loop control of inspired oxygen in premature infants | Q38379043 | ||
| The clinical use of corticosteroids in pregnancy. | Q38641374 | ||
| Does Breastmilk Influence the Development of Bronchopulmonary Dysplasia? | Q40259506 | ||
| Histological severity of fetal inflammation is useful in predicting neonatal outcome | Q40910963 | ||
| Perinatal conditions related to growth restriction and inflammation are associated with an increased risk of bronchopulmonary dysplasia | Q41621300 | ||
| Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants | Q41728000 | ||
| Fetal origins of neonatal lung disease: understanding the pathogenesis of bronchopulmonary dysplasia | Q43006465 | ||
| Oxidative stress after antenatal betamethasone: acute downregulation of glutathione peroxidase-3. | Q43238454 | ||
| Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups | Q43238545 | ||
| Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. | Q43297300 | ||
| Amplification of steroid-mediated SP-B expression by physiological levels of caffeine | Q43492192 | ||
| Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea | Q43596689 | ||
| Maternal glucocorticoids increase endotoxin-induced lung inflammation in preterm lambs | Q44241888 | ||
| Intraamniotic endotoxin increases lung antioxidant enzyme activity in preterm lambs | Q44337078 | ||
| A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants | Q44499661 | ||
| Effect of retinoic acid on oxygen-induced lung injury in the newborn rat. | Q45143319 | ||
| Antenatal steroids and antioxidant enzyme activity in preterm infants: influence of gender and timing. | Q45914982 | ||
| A Pilot Randomized Controlled Trial of Early versus Routine Caffeine in Extremely Premature Infants. | Q46003308 | ||
| Retinoids increase lung elastin expression but fail to alter morphology or angiogenesis genes in premature ventilated baboons | Q46339629 | ||
| All-trans retinoic acid and intra-amniotic endotoxin-mediated effects on fetal sheep lung | Q46411438 | ||
| Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infants | Q47309364 | ||
| Repetitive prenatal glucocorticoid therapy reduces oxidative stress in the lungs of preterm lambs | Q47875895 | ||
| Part 7: Neonatal resuscitation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations | Q48931451 | ||
| Fully automated predictive intelligent control of oxygenation (PRICO) in resuscitation and ventilation of preterm lambs. | Q50566751 | ||
| Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. | Q51003917 | ||
| Influence of sex and glucocorticoid exposure on preterm placental pro-oxidant-antioxidant balance. | Q51416349 | ||
| Sustained lung inflation at birth for preterm infants: a randomized clinical trial. | Q51664074 | ||
| Early gestational intra-amniotic endotoxin: lung function, surfactant, and morphometry. | Q51723809 | ||
| Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. | Q51726250 | ||
| Chorioamnionitis alters the response to surfactant in preterm infants. | Q51924402 | ||
| Monitoring the resuscitation of preterm infants in the delivery room using pulse oximetry. | Q52258132 | ||
| History of neonatal resuscitation. Part 2: oxygen and other drugs. | Q52915977 | ||
| Defining the Reference Range for Oxygen Saturation for Infants After Birth | Q57776979 | ||
| Effect of Sustained Inflation Length on Establishing Functional Residual Capacity at Birth in Ventilated Premature Rabbits | Q57777032 | ||
| Resuscitation of Asphyxiated Newborn Infants With Room Air or Oxygen: An International Controlled Trial: The Resair 2 Study | Q58143933 | ||
| Oxidative Stress in Fetal Lambs Exposed to Intra-amniotic Endotoxin in a Chorioamnionitis Model | Q61856098 | ||
| Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops | Q70958555 | ||
| Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes | Q72414034 | ||
| Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs | Q73667272 | ||
| Dysregulation of pulmonary elastin synthesis and assembly in preterm lambs with chronic lung disease | Q79757891 | ||
| Evidence of oxidative stress in full-term healthy infants | Q80833365 | ||
| Maternal versus fetal inflammation and respiratory distress syndrome: a 10-year hospital cohort study | Q81232796 | ||
| Effect of delayed umbilical cord clamping on blood gas analysis | Q83616374 | ||
| Early caffeine therapy and clinical outcomes in extremely preterm infants | Q84005386 | ||
| Vitamin A to prevent bronchopulmonary dysplasia: the NeoVitaA trial | Q85385287 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 15 | |
| P577 | publication date | 2016-04-13 | |
| P1433 | published in | Molecular and cellular pediatrics | Q27726660 |
| P1476 | title | Can the preterm lung recover from perinatal stress? | |
| P478 | volume | 3 |
| Q51023401 | Caffeine administration modulates TGF-β signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia. |
| Q36237898 | Detoxification of Mitochondrial Oxidants and Apoptotic Signaling Are Facilitated by Thioredoxin-2 and Peroxiredoxin-3 during Hyperoxic Injury |
| Q28075259 | Linking bronchopulmonary dysplasia to adult chronic lung diseases: role of WNT signaling |
| Q47755595 | Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia |
| Q33711647 | The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment. |
| Q42399204 | The need for coordination of research activities in pediatric lung diseases. |
| Q58551244 | The reduction in FOXA2 activity during lung development in fetuses from diabetic rat mothers is reversed by Akt inhibition |
| Q47897172 | Vascular Endothelial Mitochondrial Function Predicts Death or Pulmonary Outcomes in Preterm Infants. |
Search more.